Longeveron (LGVN) Net Equity Issued and Repurchased (2020 - 2025)
Longeveron's (LGVN) quarterly Net Equity Issued and Repurchased came in at $15.9 million in Q4 2025, up 95.24% quarter-over-quarter from $8.1 million in Q3 2024.
Longeveron (LGVN) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Longeveron's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $15.9 million for Q4 2025.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $15.9 million in Q4 2025; TTM through Dec 2025 was $28.7 million, a 122.8% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, down 61.29% from the prior year.
- Net Equity Issued and Repurchased climbed to $15.9 million in Q4 2025 per LGVN's latest filing, from $8.1 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $26.7 million in Q1 2021 and bottomed at -$1000.0 in Q4 2021.
- The 3-year median for Net Equity Issued and Repurchased is $6.4 million (2024), against an average of $9.2 million.
- Biggest YoY gain for Net Equity Issued and Repurchased was 2326.91% in 2021; the steepest drop was 2326.91% in 2021.
- Year by year, Net Equity Issued and Repurchased stood at -$1000.0 in 2021, then surged by 814500.0% to $8.1 million in 2024, then soared by 95.24% to $15.9 million in 2025.
- Per Business Quant, the three latest LGVN Net Equity Issued and Repurchased figures stand at $15.9 million (Q4 2025), $8.1 million (Q3 2024), and $4.6 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.90 Mn |
| Dec 31, 2025 | 15.90 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Mar 31, 2021 | 26.70 Mn |
| Mar 31, 2021 | 26.70 Mn |
| Mar 31, 2020 | 1.10 Mn |
| Mar 31, 2020 | 1.10 Mn |